Carlos Herrera, MD
Gynecologic Oncology · Edinburg, TXNPI 1467435982
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $46,525 of the $54,429 with a category attached, or 85.5%. AbbVie accounts for 80.6% of it on its own, with 20 other manufacturers making up the rest. Reporting peaked in 2021 at $22,261 and has fallen 99.1% since, to $197 in 2025.
Across 129 payments — averaging $421.93 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$44K
- Myriad Genetic Laboratories, Inc.$6K
- Intuitive Surgical$2K
- AstraZeneca$769
- Johnson & Johnson$704
- Baxter Healthcare$422
- plus $1K from 15 others
What the payments were for
- Consulting fees$1,4883%
- Speaking & faculty fees$46,52585%
- Food & beverage$4,4848%
- Education$1,9324%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 56 | $43,893 |
| Myriad Genetic Laboratories, Inc. | 17 | $5,840 |
| Intuitive Surgical | 4 | $1,637 |
| AstraZeneca | 7 | $769 |
| Johnson & Johnson | 14 | $704 |
| Baxter Healthcare | 8 | $422 |
| Medical Device Business Services, Inc. | 3 | $359 |
| Seagen Inc. | 3 | $340 |
| Coopersurgical, Inc. | 5 | $130 |
| Smith+Nephew | 1 | $111 |
| Teleflex LLC | 1 | $36 |
| Davol Inc. | 1 | $25 |
| KCI USA, Inc. | 1 | $25 |
| Abbott | 1 | $24 |
| Astellas Pharma US Inc | 1 | $23 |
| Stemline Therapeutics Inc. | 1 | $18 |
| Eisai Inc. | 1 | $16 |
| Bayer | 1 | $15 |
| Pfizer | 1 | $15 |
| Urgo Medical North America, LLC | 1 | $15 |
| Mimedx Group, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ORIAHNN$31,236
- Orilissa$19,293
- myRisk$3,400
- myChoice CDx$1,913
- DAVINCI XI$1,500
- LYNPARZA$480
- VISTASEAL$315
- STRATAFIX$277
- TIVDAK$240
- FLOSEAL$116
- Grafix$111
- GRAFIX PL$111
- Stravix$111
- Enseal X1$111
- EVARREST$111
- ADEPT$109
- SURGICEL Family of Absorbable Hemostats$104
- SURGIFLO Hemostatic Matrix Family of Products$104
- SURGICEL NU-KNIT$104
How this compares
$54,429 in reported general payments places this provider in the 85th percentile of 135 gynecologic oncology providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Megestrol Acetate | 72 | $5,776 |
| Estradiol | 51 | $2,018 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 39 | $1,379 |
| Imiquimod | 23 | $765 |
| Nystatin | 37 | $449 |
| Peg-3350 And ElectrolytesPeg3350/Sod Sulf,bicarb,cl/Kcl | 24 | $352 |
| Acetaminophen-CodeineAcetaminophen With Codeine | 44 | $351 |
| Metronidazole | 43 | $299 |
| Clobetasol Propionate | 13 | $298 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 14 | $198 |
| Gavilyte-GPeg3350/Sod Sulf,bicarb,cl/Kcl | 14 | $191 |
| Ibuprofen | 30 | $139 |
| Neomycin Sulfate | 23 | $129 |
| Levofloxacin | 12 | $21 |
Paid to pharmacies, not to this prescriber.
Other gynecologic oncology in Edinburg
- Lyuba LevineEdinburg$3K
- Robert ColemanHouston$864K
- Reagan StreetFort Worth$280K
- Joseph de la GarzaSan Antonio$234K
- Maurie MarkmanHouston$204K
- Dustin MandersDallas$171K
- Tiffany RedfernFort Worth$165K
- Antonio Santillan-GomezSan Antonio$162K
- Michael FrumovitzHouston$156K
- Eugene ToyEl Paso$138K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.